Finance

Lists
RAD:ASX
Radiopharm Theranostics Ltd
A$0.0070
-12.50%
(-0.0010) 1D
Sep 17, 4:10:25 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RAD...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
24.29M
Avg. vol.
10.58M
Volume
3.90M
52-wk high
A$0.04
52-wk low
A$0.01
EPS
-A$0.02
Shares outstanding
4.34B
No. of employees
14
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
24.29M
Avg. vol.
10.58M
Volume
3.90M
52-wk high
A$0.04
52-wk low
A$0.01
EPS
-A$0.02
Shares outstanding
4.34B
No. of employees
14
News stories
From web sources and news partners
About Radiopharm Theranostics Ltd
CEO-
Employees14
Founded2021
Headquarters-
SectorBiotechnology
Websiteradiopharmtheranostics.com
Last report
Jan 30, 2025
Fiscal period
Q2 2025
EPS / Est. (USD)
-$0.01 / -$0.01
+9.57%beat
Revenue / Est. (USD)
859.04K / 0.00
+∞%beat
Fiscal Q2 2025 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.10M
3.10M
3.65M
3.65M
Cost of goods sold
11.30M
11.30M
-10.05M
-10.05M
Cost of revenue
11.30M
11.30M
-10.05M
-10.05M
Research and development expenses
-
-
22.35M
22.35M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4.18M
4.18M
3.92M
3.92M
Operating expense
4.95M
4.95M
26.71M
26.71M
Total operating expenses
16.25M
16.25M
16.67M
16.67M
Operating income
-13.14M
-13.14M
-13.02M
-13.02M
Other non operating income
-
-
-434.08K
-434.08K
EBT including unusual items
-14.05M
-14.05M
-14.39M
-14.39M
EBT excluding unusual items
-13.37M
-13.37M
-13.28M
-13.28M
Income tax expense
67.15K
67.15K
-39.93K
-39.93K
Effective tax rate
-0.48%
-0.48%
0.28%
0.28%
Other operating expenses
-
-
-
-
Net income
-13.48M
-13.48M
-14.09M
-14.09M
Net profit margin
-434.67%
-434.67%
-386.15%
-386.15%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-32.55K
-32.55K
-23.64K
-23.64K
Net interest expenses
-32.55K
-32.55K
-23.64K
-23.64K
Depreciation and amortization charges
-
-
-
-
EBITDA
-12.47M
-12.47M
-12.34M
-12.34M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps